The BL genomic profile is dominated by MYC transcriptional programs and may require fewer further genetic alterations during lymphomagenesis,9 whereas DLBCL display a more aberrant genome for oncogenic transformation. The gene discussed is MYC; the disease is Burkitt lymphoma.